Mobile Menu

Search Results

Search results for: Pharma

Biopharma insights into the digital transformation

Pharma R&D productivity is decreasing. The COVID-19 pandemic has meant most pharma companies have rapidly turned towards digital strategies. The […]

Pharmacogenetic testing could save millions

According to new research from the University of East Anglia in collaboration with Boots UK and Leiden University, four million […]

“The Silent Liver Disease”: How one company is helping biopharma tackle this growing epidemic

The growing epidemic of “The Silent Liver Disease” Non-alcoholic fatty liver disease (NAFLD) is experiencing a meteoric rise globally. NAFLD […]

Barriers and facilitators to implementing pharmacogenomic screening

We summarise a recent pilot study, published as preprint in medRxiv, that explored the practical barriers and facilitators experienced by […]

Pharma stakeholders to progress data-driven development at D4 Global

Front Line Genomics is delighted to announce the launch of D4 Global: the world’s first truly global event focusing on […]

Video Mathai Mammen: Active Disruption in Pharma

The pharmaceutical industry is undergoing a big change. The industry is going through a big phase due to disruptive technologies. […]

Pharmacogenomics: Drugs, DNA and dosage

A medication that works for one person may not be as effective for others, or may cause side effects. One […]

Enabling Precision medicine for everyone: New pharmacogenomics solution launched in the US

The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.

“We need to have resilience and tolerance for failure” – Interview with Guillermo Del Angel, Alexion Pharmaceuticals

FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]

FDA releases list of evidence-based pharmacogenetic variants

Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.